LAKE FOREST, Ill. — Generic drug maker Hospira has appointed Mike Ball as CEO, effective March 28, the company said. Ball currently is president of Allergan.
Ball, who also was appointed to the company’s board, will replace Christopher Begley, who will assume the role of executive chairman.
